AR and neoplasm: Interestingly, orthotopic co-inoculation of AR-deficient human prostate stromal cells (WPMY1) and AR-negative CRPC cells (PC-3) in immunocompromised nude mice marginally reduced tumor burden relative to PC-3 tumors grown with human stromal cells expressing functional AR [262].